The New Rules of Raising Capital in MedTech

The MedTech landscape is currently navigating a significant paradox. While clinical breakthroughs are happening at a record pace, the capital required to bring those breakthroughs to the bedside is becoming increasingly concentrated. In a market where AI-driven software often captures the lion’s share of venture interest, hardware-intensive medical device companies are facing a "funding drought" that threatens to stall vital innovation.

At The Aebli Group (TAG), we’ve always believed that the best innovations deserve a path to market that isn't dictated solely by the whims of traditional venture firms. Experience tells us that when the "old way" of fundraising hits a wall, the most resilient founders look for a better blueprint.

During our latest feature from MEDevice 2026, Justin Starbird sat down with Wefunder's Jonny Price to discuss a paradigm shift that is reshaping the industry: The Community Round. This isn’t just a new way to fill a bank account; it’s a strategic evolution. By leveraging Regulation Crowdfunding, MedTech founders are now able to bypass the gatekeepers and raise capital directly from the people who care most about their success: doctors, patients, and industry peers.

In this deep dive, we explore how community-driven capital provides more than just financial runways. It creates a powerful marketing flywheel, turning hundreds of investors into a dedicated "army" of brand advocates. 

For founders tired of the traditional VC grind, Price presents a compelling case: the future of MedTech isn't just funded by the few; it's powered by the community!

LISTEN NOW: